Israel Englander Group Reports 5.2% Stake in Tenaya Therapeutics
Integrated Core Strategies (US) LLC reported beneficial ownership of 11,579,445 shares of Tenaya Therapeutics common stock, and Millennium Management LLC reported 11,581,565 shares, including shared voting and dispositive power. Israel A. Englander’s holdings were reported as equal to 5.2% of the class. The filing is submitted on Schedule 13G with an August 21, 2026 joint filing agreement.